Why the study?
Does modern management including increased PCI use reduce early mortality in AMI patients with cardiogenic shock compared to historical management?
Population
7,531 consecutive acute myocardial infarction patients presenting ≤48 h of symptom onset, including 486 with…
Comparison
Management in 2005 vs Historical management in 1995
Design
Cohort
Follow-up
1 year
Authors
Loading...
Observed CS mortality decline with PCI use is hypothesis-generating; leaves open causal confirmation by randomized trials.
Does modern management including increased PCI use reduce early mortality in AMI patients with cardiogenic shock compared to historical management?
Early mortality in AMI complicated by cardiogenic shock significantly decreased over a 10-year period, driven by increased use of PCI and recommended medications, though 1-year survival remained unchanged.
Aïssaoui et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: